false
Hamburger Menu
Catalog
Targeting HER2 in NSCLC
Targeting HER2 in NSCLC
Podcast | English | 2021 | 39 Min
Create Account
Credit
No Credit Offered
Summary
About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers. To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.
Faculty
Dr. Stephen Liu
Dr. Bob T. Li
×
Targeting HER2 in NSCLC Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English